X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (42454) 42454
Book Chapter (160) 160
Newspaper Article (20) 20
Book / eBook (17) 17
Publication (17) 17
Dissertation (15) 15
Newsletter (12) 12
Magazine Article (8) 8
Reference (8) 8
Conference Proceeding (6) 6
Web Resource (6) 6
Government Document (4) 4
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27273) 27273
animals (23153) 23153
mice (12442) 12442
signal transduction (10428) 10428
phosphorylation (9272) 9272
female (8522) 8522
cell biology (8494) 8494
biochemistry & molecular biology (8385) 8385
male (8028) 8028
oncology (7602) 7602
receptor protein-tyrosine kinases - genetics (7250) 7250
expression (6408) 6408
mutation (6199) 6199
proteins (5899) 5899
kinases (5669) 5669
activation (5629) 5629
tyrosine (5457) 5457
protein-tyrosine kinases - metabolism (5131) 5131
research (5128) 5128
cancer (5075) 5075
receptor protein-tyrosine kinases - metabolism (4913) 4913
gene expression (4833) 4833
immunology (4694) 4694
molecular sequence data (4681) 4681
cell line (4204) 4204
protein-tyrosine kinase (4063) 4063
receptor (3937) 3937
multidisciplinary sciences (3881) 3881
cells, cultured (3860) 3860
rats (3840) 3840
genetic aspects (3828) 3828
proto-oncogene proteins - genetics (3672) 3672
amino acid sequence (3667) 3667
protein-tyrosine kinases - genetics (3585) 3585
research article (3578) 3578
cell line, tumor (3536) 3536
apoptosis (3339) 3339
adult (3286) 3286
middle aged (3239) 3239
analysis (3084) 3084
physiological aspects (3079) 3079
genetics & heredity (3049) 3049
base sequence (2984) 2984
tyrosine kinase (2895) 2895
receptors (2866) 2866
transfection (2816) 2816
neurosciences (2728) 2728
cells (2726) 2726
gene (2724) 2724
tumors (2671) 2671
signal transduction - physiology (2670) 2670
medicine (2571) 2571
protein (2531) 2531
aged (2447) 2447
mice, knockout (2438) 2438
mice, inbred c57bl (2424) 2424
ligands (2402) 2402
genes (2353) 2353
biology (2322) 2322
proto-oncogene proteins - metabolism (2249) 2249
hematology (2242) 2242
signal transduction - drug effects (2233) 2233
immunohistochemistry (2229) 2229
health aspects (2215) 2215
growth-factor receptor (2144) 2144
protein binding (2136) 2136
signal-transduction (2131) 2131
science (2128) 2128
cell proliferation (2041) 2041
gene-expression (2030) 2030
tumor cells, cultured (2013) 2013
rodents (1989) 1989
rna, messenger - metabolism (1949) 1949
identification (1911) 1911
receptor tyrosine kinase (1839) 1839
epidermal growth factor (1807) 1807
signaling (1780) 1780
in-vivo (1772) 1772
medicine, research & experimental (1766) 1766
enzyme activation (1747) 1747
rna, messenger - genetics (1744) 1744
endocrinology & metabolism (1736) 1736
blotting, western (1716) 1716
protein-tyrosine kinases - antagonists & inhibitors (1704) 1704
gene expression regulation (1699) 1699
pathology (1679) 1679
gene expression regulation, neoplastic (1663) 1663
lung neoplasms - genetics (1663) 1663
polymerase chain reaction (1656) 1656
growth (1651) 1651
tyrosine - metabolism (1643) 1643
care and treatment (1608) 1608
reverse transcriptase polymerase chain reaction (1588) 1588
developmental biology (1582) 1582
metastasis (1577) 1577
inflammation (1559) 1559
inhibition (1558) 1558
lung cancer (1554) 1554
mice, transgenic (1554) 1554
kinase (1551) 1551
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (42275) 42275
Japanese (271) 271
Chinese (174) 174
French (100) 100
German (68) 68
Russian (27) 27
Spanish (24) 24
Hungarian (10) 10
Polish (10) 10
Dutch (7) 7
Czech (4) 4
Finnish (4) 4
Portuguese (4) 4
Italian (3) 3
Norwegian (3) 3
Swedish (3) 3
Danish (2) 2
Serbian (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer discovery, ISSN 2159-8290, 2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or metastatic solid tumors, including patients... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Journal Article